Transmaternal cell flow leads to antigen-experienced cord blood

Blood

Volumn 120, Issue 3, 2012, Pages 505-510

  Dierselhuis, Miranda P ^a   Blokland, Els C ^a   Pool, Jos ^a   Schrama, Ellen ^a   Scherjon, Sicco A ^a,b   Goulmy, Els ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HISTOCOMPATIBILITY ANTIGEN; HY ANTIGEN; TETRAMER;

CELL CLONE; CELL CLONING; CELL ISOLATION; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; LYSIS; MICROCHIMERISM; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

EID: 84864117113     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-02-410571     Document Type: Conference Paper

References (38)

1. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet. 1968;2(7583):1366-1369.
2. Baldomero H, Gratwohl M, Gratwohl A, et al. The EBMT activity survey 2009: trends over the past 5 years. Bone Marrow Transplant. 2011;46(4):485-501.
3. Bucher C, Stern M, Buser A, et al. Role of primacy of birth in HLA-identical sibling transplantation. Blood. 2007;110(1):468-469. (Pubitemid 47026870)
4. Gratwohl A, Doehler B, Stern M, et al. Birth order and outcome after HLA-identical sibling donor transplantation. Blood. 2009;114(27):5569-5570.
5. van Rood JJ, Scaradavou A, Stevens CE. Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect in cord blood transplantation. Proc Natl Acad Sci U S A. 2012;109(7):2509-2514.
6. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med. 1997; 337(6):373-381.
7. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344(24):1815-1822. (Pubitemid 32538694)
8. Delaney M, Ballen KK. The role of HLA in umbilical cord blood transplantation. Best Pract Res Clin Haematol. 2010;23(2):179-187.
9. Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007;369(9577):1947-1954. (Pubitemid 46874578)
10. Eapen M, Rocha V, Sanz G, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol. 2010;11(7):653-660.
11. Paloczi K. Immunophenotypic and functional characterization of human umbilical cord blood mononuclear cells. Leukemia. 1999;13(Suppl 1): S87-S89.
12. Hanley PJ, Cruz CR, Savoldo B, et al. Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes. Blood. 2009;114(9):1958-1967.
13. Micklethwaite KP, Savoldo B, Hanley PJ, et al. Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation. Blood. 2010;115(13):2695-2703.
14. Mommaas B, Stegehuis-Kamp JA, Van Halteren AG, et al. Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1. Blood. 2004;105(4):1823-1827. (Pubitemid 40223709)
15. Kuhn L, Coutsoudis A, Moodley D, et al. T-helper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breastfeeding transmission. AIDS. 2001;15(1):1-9. (Pubitemid 32055773)
16. Lee YS, Kim TS, Kim DK. T lymphocytes derived from human cord blood provide effective antitumor immunotherapy against a human tumor. BMC Cancer. 2011;11:225.
17. Okas M, Gertow J, Uzunel M, et al. Clinical expansion of cord blood-derived T cells for use as donor lymphocyte infusion after cord blood transplantation. J Immunother. 2010;33(1):96-105.
18. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A. 1996;93(2):705-708. (Pubitemid 26041153)
19. Gammill HS, Guthrie KA, Aydelotte TM, Waldorf KMA, Nelson JL. Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host? Blood. 2010;116(15):2706-2712.
20. Verdijk RM, Kloosterman A, Pool J, et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood. 2004;103(5):1961-1964. (Pubitemid 38268999)
21. van Halteren AGS, Jankowska-Gan E, Joosten A, et al. Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood. 2009;114(11):2263-2272.
22. Goulmy E, Termijtelen A, Bradley BA, van Rood JJ. Y-antigen killing by T cells of women is restricted by HLA. Nature. 1977;266(5602):544-545. (Pubitemid 8079243)
23. Goulmy E, Schipper R, Pool J, et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med. 1996;334(5):281-285. (Pubitemid 26033083)
24. Mutis T, Gillespie G, Schrama E, et al. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med. 1999;5(7):839-842. (Pubitemid 29318622)
25. Oosten LE, Blokland E, Van Halteren AG, et al. Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes. Blood. 2004;104(1):224-226. (Pubitemid 38879861)
26. Gillespie G, Mutis T, Schrama E, et al. HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligand. Hematol J. 2001;1(6):403-410.
27. Yan Z, Lambert NC, Guthrie KA, et al. Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med. 2005;118(8):899-906. (Pubitemid 41097469)
28. Koopmans M, Kremer H, I, Baelde HJ, et al. Chimerism in kidneys, livers and hearts of normal women: implications for transplantation studies. Am J Transplant. 2005;5(6):1495-1502. (Pubitemid 40839444)
29. Biran V, Bornes M, Aboura A, et al. A long-term competent chimeric immune system in a dizygotic dichorionic twin. Pediatrics. 2011;128(2):e458-e463.
30. de Bellefon LM, Heiman P, Kanaan SB, et al. Cells from a vanished twin as a source of microchimerism 40 years later. Chimerism. 2010;1(2):56-60.
31. Moldenhauer LM, Diener KR, Thring DM, et al. Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy. J Immunol. 2009; 182(12):8080-8093.
32. Quayle AJ, Xu C, Mayer KH, Anderson DJ. T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis. 1997;176(4):960-968. (Pubitemid 27411038)
33. Peters B, Whittall T, Babaahmady K, et al. Effect of heterosexual intercourse on mucosal alloimmunisation and resistance to HIV-1 infection. Lancet. 2004;363(9408):518-524. (Pubitemid 38229452)
34. Maile R, Wang B, Schooler W, et al. Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers. J Immunol. 2001;167(7):3708-3714. (Pubitemid 32910815)
35. Xu XN, Screaton GR. MHC/peptide tetramer-based studies of T cell function. J Immunol Methods. 2002;268(1):21-28. (Pubitemid 35223104)
36. Mutis T, Verdijk R, Schrama E, et al. Feasibility of immunotherapy of relapsed leukemia with ex vivo- generated cytotoxic T lymphocytes specific for hematopoietic system- restricted minor histocompatibility antigens. Blood. 1999;93(7):2336-2341. (Pubitemid 29153637)
37. Koene G, Mulder A, van der Ven K, et al. Human monoclonal antibodies as a tool for the detection of HLA class I allele-specific expression loss in head-and-neck squamous cell carcinoma and corresponding lymph node metastases. Hum Immunol. 2006;67(9):692-699. (Pubitemid 44416010)
38. Mulder A, Kardol MJ, Arn JS, et al. Human monoclonal HLA antibodies reveal interspecies cross-reactive swine MHC class I epitopes relevant for xenotransplantation. Mol Immunol. 2010;47(4):809-815.